March 01, 2017
A Delaware federal judge on Wednesday wiped out Genentech's newly filed lawsuit accusing Amgen of improperly concealing information about a proposed biosimilar of cancer drug Avastin, finding that the complaint isn't allowed under a landmark Federal Circuit ruling.
February 16, 2017
Amgen is hypocritically withholding information about its proposed biosimilar of cancer drug Avastin and thereby undercutting potential patent litigation, Genentech charged in a complaint filed Wednesday in Delaware federal court.